H.R. 482 (107th): RU-486 Patient Health and Safety Protection Act

Introduced:
Feb 06, 2001 (107th Congress, 2001–2002)
Status:
Died (Referred to Committee)
Sponsor
David Vitter
Representative for Louisiana's 1st congressional district
Party
Republican
Text
Read Text »
Last Updated
Feb 06, 2001
Length
3 pages
Related Bills
H.R. 486 (108th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: Jan 29, 2003

S. 251 (identical)

Referred to Committee
Last Action: Feb 06, 2001

 
Status

This bill was introduced on February 6, 2001, in a previous session of Congress, but was not enacted.

Progress
Introduced Feb 06, 2001
Referred to Committee Feb 06, 2001
 
Full Title

To require the Food and Drug Administration to establish restrictions regarding the qualifications of physicians to prescribe the abortion drug commonly known as RU-486.

Summary

No summaries available.

Cosponsors
37 cosponsors (35R, 2D) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


2/6/2001--Introduced.
RU-486 Patient Health and Safety Protection Act - Restricts the prescribing of the drug mifepristone (commonly referred to as RU-486, to be marketed as Mifeprex) to physicians who meet specified requirements.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 482 (107th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus